Both in Pharmaceuticals
Arbutus Biopharma vs Wave Life Sciences
Over the past year ABUS returned −11.6% and WVE returned −55.7%; their daily moves had a correlation of 0.19.
ABUS −11.6% WVE −55.7%Growth of $1, one year, split-adjusted
| Metric | ABUS | WVE |
|---|---|---|
| Price | $4.05 | $3.68 |
| Market cap | $802.3M | $725.8M |
| Today | +4.38% | +2.79% |
| 1 month | −9.6% | +4.5% |
| 6 months | −8.4% | −49.5% |
| Year to date | −15.8% | −78.4% |
| 1 year | −11.6% | −55.7% |
| Revenue growth (YoY) | −90.6% | +72.9% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −512.0% | −470.5% |
| P/E (TTM) | 5.2× | — |
| Price / sales | 4.4× | 10.2× |
| Net cash | $89.5M | $430.7M |
| Dividend yield | — | — |
| Volatility (60d) | 38.1% | 51.7% |
| Short % of float | 15.6% | 17.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).